leisure time -WSS

leisure time

author：fashion 2025-10-01 02:16:21 - browse：12

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Johnson & Johnson sues to stop Medicare negotiation

WSS

A look at other Americans who have crossed into North Korea over the years

A letter from the executive editor: The 2023 STATUS List

Flagship, Pfizer team up in deal worth up to $7 billion

BridgeBio heart drug succeeds in pivotal study

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Alkermes shareholders re

Being 'nonadherent' patient made me a more empathetic doctor

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Beware reading your test results before your doctor does

United colonoscopy coverage change 'may cost lives,' doctors say

Study: Hearing aids may slow cognitive decline in those at risk

Trump demands the U.S. pay no more for drugs than other countries … again

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Bright Health sells Medicare Advantage business to Molina

AstraZeneca lung cancer study comes in below expectations

explore

BridgeBio heart drug succeeds in pivotal study

Study: Hearing aids may slow cognitive decline in those at risk

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Dexcom's push to bring CGM to type 2 diabetes patients

Use doctors trained outside the U.S. to ease the physician shortage

focus

entertainment

focus

focus